Efficacy and safety of ascending doses of moxidectin against Strongyloides stercoralis infections in adults: a randomised, parallel-group, single-blinded, placebo-controlled, dose-ranging, phase 2a trial
Daniela Hofmann, Somphou Sayasone, Khanpaseuth Sengngam, Bounthunh Chongvilay, Jan Hattendorf, Jennifer Keiser
Topics & Concepts
MoxidectinPlaceboStrongyloides stercoralisMedicineRandomized controlled trialAdverse effectClinical endpointInternal medicineIvermectinVeterinary medicineHelminthsImmunologyPathologyAlternative medicineParasites and Host InteractionsParasitic Diseases Research and TreatmentHelminth infection and control